Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
Clinical trial NCT07503652 · RECRUITING
Trial details
- NCT number
- NCT07503652
- Sponsor
- First Hospital of China Medical University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.